Evidence map›Paper›PMID 28900866›Full record

ArticleJournal of neurovirology2017

Progressive multifocal leukoencephalopathy 11 years after liver transplantation: a case report.

Ana Moreno-Estébanez, Javier Almeida Velasco, Tomás Pérez-Concha, Tirso González-Pinto, Iñigo Gabilondo

Abstract readCase Reports
PubMed Publisher
In one paragraph

Article in Journal of neurovirology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.2field-weighted citation impact, top 41% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 2 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Ana Moreno-EstébanezDepartment of Neurology, Cruces University Hospital, Plaza Cruces S/N, 48903, Barakaldo, Basque Country, Spain. ana.morenoestebanez@osakidetza.eus.ORCID 0000-0002-6326-6856
Javier Almeida VelascoDepartment of Neurology, Cruces University Hospital, Plaza Cruces S/N, 48903, Barakaldo, Basque Country, Spain.
Tomás Pérez-ConchaDepartment of Neurology, Cruces University Hospital, Plaza Cruces S/N, 48903, Barakaldo, Basque Country, Spain.
Tirso González-PintoDepartment of Neurology, Cruces University Hospital, Plaza Cruces S/N, 48903, Barakaldo, Basque Country, Spain.
Iñigo GabilondoDepartment of Neurology, Cruces University Hospital, Plaza Cruces S/N, 48903, Barakaldo, Basque Country, Spain.
Hospital de Cruces · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Progressive multifocal leukoencephalopathy (PML) is an opportunistic infection of the central nervous system caused by JC virus. Only ten cases of PML have been reported so far in liver transplant recipients. We present a case of liver posttransplantation PML with characteristic clinical and brain MRI findings, but with an atypical late onset, developed 11 years after transplantation and after single-drug, long-term (8 years), and low-dose (750 mg twice a day) immunosuppression with mycophenolate mofetil (MMF). This is the latest onset of PML associated to liver transplant reported. The present case should help physicians to be aware of PML after transplantation, even in the long term and even under low doses of immunosuppressants, especially MMF.

Indexed as

Immunocompromised HostLiver TransplantationAgedBrainFemaleHumansImmunosuppressive AgentsJC VirusLeukoencephalopathy, Progressive MultifocalLiverMagnetic Resonance ImagingMycophenolic AcidOpportunistic InfectionsImmunosuppressive AgentsMycophenolic AcidLiver transplantationMycophenolate mofetilProgressive multifocal leukoecephalopathy

Identifiers

PMID28900866
OpenAlexW2755342532

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.